Neonatal randomised point-of-care trials in the UK
Faculti
Imperial College London

Randomised point-of-care trials (POCT) or registry trials offer a potentially efficient, convenient and cost-effective alternative to conventional randomised controlled trials. Dr Chris Gale and Professor Neena Modi, Imperial College London, discuss the use of information present in an existing database, registry or electronic patient record (EPR), POCT eliminate the need for duplicative data collection. Neonatal medicine is well placed to use this methodology; an existing national resource, the National Neonatal Research Database (NNRD), holds detailed data extracted from the neonatal EPR of all National Health Service neonatal units in England, Wales and Scotland; contributing units are known as the UK Neonatal Collaborative (UKNC).

Transcript

Topic Overview

Try PhD level

Ask Faculti AI: Explore the transcript or get definitions

Loading...

Related Videos

Queen Mary University of London

DNA methylation predicts high-grade cervical neoplasia

University of Bath

Shared Genetic Architecture in Anorexia Nervosa

Imperial College London

Gene therapy for heart failure: The end of the beginning?

Imperial College London

Large Stem Cell-Derived Cardiomyocyte Grafts: Cellular Ventricular Assist Devices?

Neonatal randomised point-of-care trials in the UK